Second-generation argon plasma coagulation: two-center experience with 600 patients.

Second-generation argon plasma coagulation: two-center experience with 600 patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Second-generation argon plasma coagulation: two-center experience with 600 patients. Abstract Text:

BACKGROUND AND AIM: Second-generation argon plasma coagulation (APC; APC 2/VIO APC) with its modes 'forced', 'pulsed', and 'precise' is a further development of the ICC/APC 300 system (first-generation APC). Until now, only limited data has existed on the use of APC 2. METHODS: Fundamental data on the characteristics of the various APC 2 modes and clinical data from more than 600 patients treated in two high-volume endoscopy centers were analyzed. On the basis of these data, recommendations for the use of APC in daily gastroenterological practice were made. RESULTS: In comparison to the ICC system, second-generation APC offers a broadened bandwidth of settings including different APC modes and a range of power settings from 1 to 120 W. Using the various modes of APC 2 in a variety of gastrointestinal diseases, minor complications were observed in 9-21% of patients. Major complications occurred in 1-7% of patients. CONCLUSIONS: In a two-center experience treating a large group of patients with a wide variety of gastrointestinal conditions, the different APC 2 modes appeared to be safe and effective. Certain preventive measures before and during clinical application are recommended in order to avoid complications.

Second-generation argon plasma coagulation: two-center experience with 600 patients. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Second-generation argon plasma coagulation: two-center experience with 600 patients. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of gastroenterology and hepatology

VOLUME: 23

Page Numbers: 872-8

Journal Abbreviation: J. Gastroenterol. Hepatol.

ISSN: 1440-1746

DAY: 20

MONTH: Jun

YEAR: 2008

Second-generation argon plasma coagulation: two-center experience with 600 patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8607909

Second-generation argon plasma coagulation: two-center experience with 600 patients. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Second-generation argon plasma coagulation: two-center experience with 600 patients. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Second-generation argon plasma coagulation: two-center experience with 600 patients.

AFFILIATION: Department of Internal Medicine II, HSK Wiesbaden, Wiesbaden, Germany. HSManner@gmx.de

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Gastroenterol Hepatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Second-generation argon plasma coagulation: two-center experience with 600 patients Related Publications

• Appendico-vesical fistula. A new case and a brief review of the literature.
• Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.
• Atrophic arthritis, splenomegaly and leukopenia; report of two cases.
• Forefoot vasoconstrictor response to increased venous pressure in normal subjects and in arteriosclerotic patients.
• Leben als Konflikt. Zur Biographie Alexander Mitscherlich [Living as conflict: The life of Alexander Mitscherlich].
• Letter: Abortion and promiscuity.
• Measurement of central hemodynamic parameters during preoperative exercise testing in patients suspected of arteriosclerotic heart disease. Value in predicting postoperative cardiac complications.
• Non-inflammable cyclopropane-helium and oxygen mixtures for use in the reserve midget anesthesia machine.
• Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
• Reply to frain and warye.
• Second-generation argon plasma coagulation: two-center experience with 600 patients.
• The design of clinical graft studies.
• The development of non-flammable cyclopropane-helium and oxygen mixtures for use in the reserve midget anesthesia machine in miniature, color-designated steel cyclinders.
• Treatment of thromboangiitis obliterans and thrombophlebitis with tetraethylammonium chloride.
• Who is steering the ship? External influences on infection control programs.
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [ON THE THYROID GLANDS OF SEALS AND ALPINE RABBITS.]